Sernova Corp (SVA : TSX)
Common Stock
Follow SVA
SVA
Sernova Corp
Performance
1 Day
-10.00%
1 Week
-14.29%
1 Month
-18.18%
YTD
-28.00%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$33.99M
52W High
$0.20
52W Low
$0.09
P/E Ratio
9.00
50 Day MA
$0.11
200 Day MA
$0.14
Beta
0.67
Dividend Yield
-
Performance history
SVA returns since 2023
Sernova Corp has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −88.0% (Nov 2023 to Sep 2026).
1 year / yr
−35.7%
3 years / yr
−50.0%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−5.4%
- 2024−67.1%
- 2025−43.5%
- 2026*−30.8%
* Partial year (first year of data, or year to date).
$10,000 invested in SVA
- 1 year ago$6,429
- 2023 (start of our data)$1,216
- Best year
- 2025: −43.5%
- Worst year
- 2024: −67.1%
- All-time high in our data
- $1 on Nov 28, 2023 · now −88.0%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
SVA earnings history
Sernova Corp beat the EPS estimate in 0 of its last 4 reported quarters.
Next report
Dec 17, 2026 · after close
EPS estimate −$0.01
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jul 31, 2026 | Sep 10, 2026 | −$0.01 | −$0.01 | +0.0% |
| Apr 30, 2026 | Jun 11, 2026 | −$0.01 | −$0.01 | +0.0% |
| Jan 31, 2026 | Mar 13, 2026 | −$0.01 | −$0.01 | +0.0% |
| Oct 31, 2025 | Dec 19, 2025 | −$0.01 | −$0.01 | +0.0% |
| Jul 31, 2025 | Sep 15, 2025 | −$0.01 | −$0.02 | +50.0% |
| Apr 30, 2025 | Jun 13, 2025 | −$0.01 | −$0.02 | +50.0% |
| Jan 31, 2025 | Mar 14, 2025 | −$0.02 | −$0.03 | +33.3% |
| Oct 31, 2024 | Dec 23, 2024 | −$0.02 | −$0.03 | +33.3% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past SVA? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/19/2026 | $0.10 | $0.10 | $0.09 | $0.09 | $0.09 | 99,010 |
| 11/18/2026 | $0.10 | $0.10 | $0.09 | $0.10 | $0.10 | 300,727 |
| 11/17/2026 | $0.11 | $0.12 | $0.10 | $0.10 | $0.10 | 303,582 |
| 11/16/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 111,297 |
| 11/13/2026 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 6,310 |
| 11/12/2026 | $0.12 | $0.12 | $0.10 | $0.10 | $0.10 | 102,090 |
| 11/11/2026 | $0.11 | $0.12 | $0.11 | $0.11 | $0.11 | 42,611 |
| 11/10/2026 | $0.11 | $0.12 | $0.11 | $0.11 | $0.11 | 22,500 |
| 11/9/2026 | $0.11 | $0.12 | $0.11 | $0.11 | $0.11 | 58,555 |
| 11/6/2026 | $0.10 | $0.11 | $0.10 | $0.11 | $0.11 | 32,010 |
Analyst Price Targets
Based on analyst covering SVA · as of Sep 17, 2026
Wall Street analysts forecast SVA stock price to rise 1011.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.00
+1011.1% Upside
Current Price
C$0.09
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SVA's historical volatility
30-Day Vol
84.4%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.06 – C$0.11 |
| 60 trading days | C$0.08 | C$0.05 – C$0.12 |
| 90 trading days | C$0.08 | C$0.05 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sernova Corp
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-8.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- -726.29%
- EPS (Diluted)
- 0.01
- Book Value
- -0.06
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About SVA
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GRC | Gold Springs Resource Corp | $0.06 | +37.50% |
| MDNA | Medicenna Therapeutics Corp | $0.22 | +22.22% |
| DRX | ADF Group Inc. | $20.78 | +20.88% |
| DND | Dye & Durham Ltd | $0.98 | +13.95% |
| T | Telus Corp | $15.50 | +13.72% |
| BU | Burcon NutraScience Corporation | $0.85 | +13.33% |
| DII-B | Dorel Industries Inc | $1.35 | +8.87% |
| PYR | PyroGenesis Canada Inc. | $0.19 | +8.57% |
Free with a Wealth Awesome account
Keep analysing SVA, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.